Corona vaccine to be tested for children in India, Covaxin gets trial permission- Amid the second wave of Corona in the country, the most concern is being raised about children. The reason for this is that till now only people above the age of 18 years are being given the vaccine dose. However, the US has yesterday approved the emergency use of a vaccine made for children in its country. Now its hope is also raised in India. Covaxin, prepared in collaboration with Bharat Biotech and ICMR, has been approved for trials for children from 2 years to 18 years.
According to reports, the trial is planned to be conducted among 525 participants at several locations. The hospitals include All India Institute of Medical Sciences (AIIMS), Delhi and AIIMS located in Patna. The purpose of conducting the test would be to evaluate the covaxine vaccine in children for safety, reactivity, and immunity. All these parameters are necessary to be approved for use in the general public.
An expert committee on Tuesday recommended clinical trials for the second / third stage of Bharat Biotech’s Covid-19 vaccine covaxine for ages 2-18. Official sources have given this information. He said that this test will be done at various places including AIIMS in Delhi and Patna and the Meditrina Institute of Medical Sciences, Nagpur.
The Covid-19 Subject Expert Committee of the Central Drugs Standard Control Organization (CDSCO) on Tuesday discussed the application made by Bharat Biotech. It was requested to allow the second / third phase of the test to assess the covaxine vaccine among other things, including increasing the safety and immunity in children from two to 18 years.
A source said that after detailed deliberations on the company’s application, the committee had recommended allowing the proposed second/third stage test.
Coronation of Corona virus still continues in the country. For the last three days, even though the daily cases of corona virus have been declining, the death toll is not under control. The Subject Expert Committee approved covaxine for the second and third phases of clinical trials for 2–18-year-olds. At the same time, Dr. Harsh Vardhan will hold a meeting with the health ministers of eight states. Delhi Deputy Chief Minister Manish Sisodia said that vaccine exports should be completely banned.
